These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19451035)

  • 21. Compartmentalization of inflammation in the CNS: a major mechanism driving progressive multiple sclerosis.
    Meinl E; Krumbholz M; Derfuss T; Junker A; Hohlfeld R
    J Neurol Sci; 2008 Nov; 274(1-2):42-4. PubMed ID: 18715571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pathogenesis of multiple sclerosis: relating human pathology to experimental studies.
    Ludwin SK
    J Neuropathol Exp Neurol; 2006 Apr; 65(4):305-18. PubMed ID: 16691112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B-cell differentiation in the CNS of patients with multiple sclerosis.
    Corcione A; Aloisi F; Serafini B; Capello E; Mancardi GL; Pistoia V; Uccelli A
    Autoimmun Rev; 2005 Nov; 4(8):549-54. PubMed ID: 16214094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunity and neurodegeneration: new concepts in multiple sclerosis].
    Lalive PH; Schluep M; Chofflon M; Du Pasquier R
    Rev Med Suisse; 2006 May; 2(64):1166-8, 1170. PubMed ID: 16734188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Herpesvirus and multiple sclerosis.
    Simmons A
    Herpes; 2001 Nov; 8(3):60-3. PubMed ID: 11867021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [MSRV retrovirus and gliotoxin protein: potential biological markers in multiple sclerosis?].
    Perron H
    Ann Biol Clin (Paris); 1998; 56(4):427-38. PubMed ID: 9754278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The destructive alliance: interactions of leukocytes, cerebral endothelial cells, and the immune cascade in pathogenesis of multiple sclerosis.
    Minagar A; Carpenter A; Alexander JS
    Int Rev Neurobiol; 2007; 79():1-11. PubMed ID: 17531835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early treatment of multiple sclerosis to prevent neurologic damage.
    Coyle PK
    Neurology; 2008 Dec; 71(24 Suppl 3):S3-7. PubMed ID: 19064872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The interest of multiple sclerosis attacks. Physiopathology and therapy].
    de Andrés C
    Rev Neurol; 2003 Jun 1-15; 36(11):1058-64. PubMed ID: 12808503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Multiple sclerosis and measles virus].
    Panelius M
    Duodecim; 1971; 87(22):1462-4. PubMed ID: 5136499
    [No Abstract]   [Full Text] [Related]  

  • 31. B- and T-cell responses in multiple sclerosis: novel approaches offer new insights.
    Hohlfeld R; Meinl E; Dornmair K
    J Neurol Sci; 2008 Nov; 274(1-2):5-8. PubMed ID: 18707694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Vogt J; Paul F; Aktas O; Müller-Wielsch K; Dörr J; Dörr S; Bharathi BS; Glumm R; Schmitz C; Steinbusch H; Raine CS; Tsokos M; Nitsch R; Zipp F
    Ann Neurol; 2009 Sep; 66(3):310-22. PubMed ID: 19798635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple sclerosis and measles virus.
    Ohara Y
    Jpn J Infect Dis; 1999 Oct; 52(5):198-200. PubMed ID: 10680085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple sclerosis: human model for EAE?
    Hohlfeld R
    Eur J Immunol; 2009 Aug; 39(8):2036-9. PubMed ID: 19672899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Translational Mini-Review Series on B cell subsets in disease. B cells in multiple sclerosis: drivers of disease pathogenesis and Trojan horse for Epstein-Barr virus entry to the central nervous system?
    Meier UC; Giovannoni G; Tzartos JS; Khan G
    Clin Exp Immunol; 2012 Jan; 167(1):1-6. PubMed ID: 22132878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The history of multiple sclerosis: the changing frame of the disease over the centuries.
    Murray TJ
    J Neurol Sci; 2009 Feb; 277 Suppl 1():S3-8. PubMed ID: 19200863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The multiple sclerosis trait and the development of multiple sclerosis: genetic vulnerability and environmental effect.
    Poser CM
    Clin Neurol Neurosurg; 2006 Mar; 108(3):227-33. PubMed ID: 16406307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel therapeutic strategies for multiple sclerosis--a multifaceted adversary.
    Lopez-Diego RS; Weiner HL
    Nat Rev Drug Discov; 2008 Nov; 7(11):909-25. PubMed ID: 18974749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The MSMV hypothesis: measles virus and multiple sclerosis, etiology and treatment.
    Tucker WG; Andrew Paskauskas R
    Med Hypotheses; 2008 Nov; 71(5):682-9. PubMed ID: 18703291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The virtues and vices of harnessing HSV vectors for CNS autoimmunity modulation.
    Hukkanen V; Nygårdas M
    Immunotherapy; 2013 Sep; 5(9):911-3. PubMed ID: 23998724
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.